Prometheus Biosciences
RXDX
$199.92
Share price
0.00%
Change (1 day)
360.96%
Change (1 year)
Categories
P/S ratio for Prometheus Biosciences (RXDX)
P/S ratio as of April 2024 (TTM): > 1000
According to Prometheus Biosciences's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2392.62. At the end of 2023 the company had a P/S ratio of > 1000.
P/S ratio history for Prometheus Biosciences from 2021 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | > 1000 | 72.51% |
| 2022 | 751 | 52.63% |
| 2021 | 492 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Epizyme EPZM | 4.67 | -99.80% | 🇺🇸 USA |
 Akebia Therapeutics AKBA | 1.47 | -99.94% | 🇺🇸 USA |
 Agenus
AGEN | 0.8656 | -99.96% | 🇺🇸 USA |